Physician profile
Flavio Cordano
NPI 1427059237
$1,031.22
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $154 · 2021: $356 · 2022: $211 · 2023: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $296.58 | 2019-2023 | T2 |
| Amgen INC. | $190.70 | 2019-2022 | |
| Pfizer INC. | $88.36 | 2020-2021 | |
| Boston Scientific Corporation | $76.80 | 2019-2021 | |
| Bausch Health US, LLC | $74.67 | 2020 | |
| Collegium Pharmaceutical, INC. | $57.79 | 2021 | |
| Dexcom, INC. | $48.98 | 2021 | |
| Orthofix Medical, INC. | $47.72 | 2021-2022 | |
| Novo Nordisk INC | $37.18 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $35.63 | 2019-2022 | |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Treace Medical Concepts, INC. | $19.71 | 2022 | |
| Shire North American Group INC | $18.24 | 2019 | |
| Horizon Therapeutics Plc | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Flavio Cordano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.